Home › High Blood Pressure › New Jersey › Brick
High Blood Pressure clinical trials in Brick, NJ
3 studies for High Blood Pressure are looking for participants at sites in and around Brick (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
RecruitingPhase 3
- Research Site, Eatontown · 17 mi away
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
Recruiting
- Jersey Shore University Medical Center, Neptune City · 11 mi away
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Brick
About High Blood Pressure
High blood pressure (hypertension) develops when blood flows through arteries at higher than normal pressures. It increases the risk for heart disease and stroke.
More about High Blood Pressure on MedlinePlus
High Blood Pressure trials in other cities
- Chicago, IL22 studies
- Boston, MA21 studies
- Dallas, TX16 studies
- Nashville, TN13 studies
- Houston, TX11 studies
- Birmingham, AL11 studies
- Atlanta, GA10 studies
- Tucson, AZ10 studies
- Durham, NC10 studies
- New York City, NY9 studies
- Miami, FL9 studies
- Baltimore, MD9 studies
Other studies in Brick
- Acute Myeloid Leukemia7 studies
- Breast Cancer6 studies
- Chronic Kidney Disease5 studies
- Nausea and Vomiting4 studies
- Non-Small Cell Lung Cancer4 studies
- Cardiovascular Disease4 studies
- Lung Cancer4 studies
- Colorectal Cancer3 studies
- Obesity3 studies
- Cancer (all types)3 studies
- Melanoma3 studies
- Myeloproliferative Neoplasms3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.